Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice

Vaccine

Volumn 21, Issue 23, 2003, Pages 3212-3218

  Takada, Ayato ^a   Matsushita, Sachiko ^b   Ninomiya, Ai ^b   Kawaoka, Yoshihiro ^a   Kida, Hiroshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Heterosubtypic immunity; Inactivated vaccine; Influenza virus

Indexed keywords

EPITOPE; FORMALDEHYDE; HEMAGGLUTININ; IMMUNOGLOBULIN A ANTIBODY; INFLUENZA VACCINE; MATRIX PROTEIN; NUCLEOPROTEIN; SIALIDASE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; INFLUENZA VIRUS A; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

EID: 0038120851     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00234-2     Document Type: Article

References (37)

1. Webster R.G., Bean W.J., Gorman T.O., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:1992;152-179.
2. Röhm C., Zhou N., Süss J., MacKenzie J., Webster R.G. Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology. 217:1996;508-516.
3. Wright PF, Webster RG. Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 4th ed. Philadelphia: Williams & Wilkins; 2001. p. 1533-79.
4. Subbarao K., Katz J. Avian influenza viruses infecting humans. Cell Mol. Life Sci. 57:2000;1770-1784.
5. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H.et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 279:1998;393-396.
6. Claas E.C.J., van Beek R., de Jong J.C., Rimmelzwaan G.F., Senne D.A.et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 351:1998;472-477.
7. Yuen K.Y., Chan P.K., Peiris M., Tsang D.N.C., Que T.L., Shortridge K.F.et al. Members of the H5N1 Study Group. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 351:1998;467-471.
8. Peiris M., Yuen K.Y., Leung C.W., Chan K.H., Ip P.L., Lai R.W.et al. Human infection with influenza H9N2. Lancet. 354:1999;916-917.
9. Takada A., Shimizu Y., Kida H. Protection of mice against Aujeszky's disease virus infection by intranasal vaccination with inactivated virus. J. Vet. Med. Sci. 56:1994;633-637.
10. Takada A., Kida H. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Vet. Microbiol. 50:1996;17-25.
11. Ada G.L., Jones P.D. The immune response to influenza infection. Corr. Top. Microbiol. Imuunol. 128:1986;1-54.
12. Liang S., Mozdzanowska K., Palladino G., Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152:1994;1653-1661.
13. Epstein S.L., Lo C.Y., Misplon J.A., Lawson C.M., Hendrickson B.A., Max E.E.et al. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, β2-microglobulin-deficient, and J chain-deficient mice. J. Immunol. 158:1997;1222-1230.
14. Nguyen H.H., Moldoveanu Z., Novak M.J., van Ginkel F.W., Ban E., Kiyono H.et al. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology. 254:1999;50-60.
15. Nguyen H.H., van Ginkel F.W., Vu H.L., Novak M.J., McGhee J.R., Mestecky J. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice. J. Virol. 74:2000;5495-5501.
16. Nguyen H.H., van Ginkel F.W., Vu H.L., McGhee J.R., Mestecky J. Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J. Infect Dis. 183:2001;368-376.
17. Yap K.L., Ada G.L. The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen. Scand J. Immunol. 8:1978;413-420.
18. Webster R.G., Askonas B.A. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10:1980;396-401.
19. Yewdell J.W., Bennink J.R., Smith G.L., Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 82:1985;1785-1789.
20. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
21. Flynn K.J., Belz G.T., Altman J.D., Ahmed R., Woodland D.L., Doherty P.C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity. 8:1998;683-691.
22. Ulmer J.B., Fu T.M., Deck R.R., Friedman A., Guan L., DeWitt C.et al. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 72:1998;5648-5653.
23. Epstein S.L., Misplon J.A., Lawson C.M., Subbarao E.K., Connors M., Murphy B.R. β2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol. 150:1993;5484-5493.
24. Takada A., Kuboki N., Okazaki K., Ninomiya A., Tanaka H., Ozaki H.et al. Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J. Virol. 73:1999;8303-8307.
25. Tumpey T.M., Renshaw M., Clements J.D., Katz J.M. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J. Virol. 75:2001;5141-5150.
26. Kida H., Brown L.E., Webster R.G. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology. 122:1982;38-47.
27. Takada A., Kida H. Induction of protective antibody responses against pseudorabies virus by intranasal vaccination with glycoprotein B in mice. Arch. Virol. 140:1995;1629-1635.
28. Kilbourne E.D., Laver W.G., Schulman J.L., Webster R.G. Antiviral activity of antiserum specific for an influenza virus neuraminidase. J. Virol. 2:1968;281-288.
29. Schulman L.J., Khakpour M., Kilbourne E.D. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J. Virol. 2:1968;778-786.
30. Murphy B.R., Kasel J.A., Chanock R.M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. New Engl. J. Med. 286:1972;1329-1332.
31. Mazanec M.B., Kaetzel C.S., Lamm M.E., Fletcher D., Nedrud J.G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA. 89:1992;6901-6905.
32. Mazanec M.B., Coudret C.L., Fletcher D.R. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69:1995;1339-1343.
33. Bomsel M., Heyman M., Hocini H., Lagaye S., Belec L., Dupont C.et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity. 9:1998;277-287.
34. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 272:1996;104-107.
35. Feng N., Lawton J.A., Gilbert J., Kuklin N., Vo P., Prasad B.V.et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J. Clin. Invest. 109:2002;1203-1213.
36. Lamb RA, Krug RM. Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 4th ed. Philadelphia: Williams & Wilkins; 2001. p. 1487-531.
37. Tamura S., Samegai Y., Kurata H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine. 6:1988;409-413.